FibroBiologics Ownership | Who Owns FibroBiologics?
FibroBiologics Ownership Summary
FibroBiologics is owned by 13.21% institutional investors, 19.57% insiders, and 67.22% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.94% of FBLG shares.
FBLG Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | FibroBiologics | 13.21% | 19.57% | 67.22% |
Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 750.90K | 1.94% | $467.21K |
Cascade financial partners | 290.58K | 0.75% | $180.80K |
Cerity partners | 128.11K | 0.33% | $79.71K |
Requisite capital management | 109.71K | 0.28% | $68.26K |
American institute for advanced investment management, llp | 88.21K | 0.23% | $54.88K |
Marshall wace, llp | 78.62K | 0.20% | $48.74K |
Wiley bros.-aintree capital | 70.00K | 0.18% | $43.55K |
Y-intercept (hong kong) | 59.54K | 0.15% | $37.05K |
Xtx topco | 45.95K | 0.12% | $28.59K |
Rmr wealth builders | 38.36K | 0.10% | $23.87K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
American institute for advanced investment management, llp | 88.21K | 0.04% | $54.88K |
Cascade financial partners | 290.58K | 0.02% | $180.80K |
Requisite capital management | 109.71K | 0.01% | $68.26K |
Saxon interests | 21.21K | 0.01% | $19.09K |
Rmr wealth builders | 38.36K | 0.00% | $23.87K |
Point72 asia (singapore) pte. | 16.49K | 0.00% | $10.26K |
Xtx topco | 45.95K | 0.00% | $28.59K |
Skopos labs | 11.50K | 0.00% | $7.16K |
Y-intercept (hong kong) | 59.54K | 0.00% | $37.05K |
Cahaba wealth management | 14.70K | 0.00% | $9.15K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Marshall wace, llp | 78.62K | 0.00% | 78.62K |
Wiley bros.-aintree capital | 70.00K | 0.00% | 70.00K |
Y-intercept (hong kong) | 59.54K | 0.00% | 59.54K |
Hrt financial lp | 37.80K | 0.00% | 37.80K |
Cerity partners | 128.11K | 0.00% | 34.70K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 750.90K | - | -1.01M |
Charles schwab investment management | - | - | -69.81K |
Jane street group | - | - | -61.07K |
Bank of new york mellon | - | - | -51.42K |
O'shaughnessy asset management | - | - | -40.40K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Marshall wace, llp | 78.62K | 0.00% | 78.62K | $48.74K |
Wiley bros.-aintree capital | 70.00K | 0.00% | 70.00K | $43.55K |
Y-intercept (hong kong) | 59.54K | 0.00% | 59.54K | $37.05K |
Hrt financial lp | 37.80K | 0.00% | 37.80K | $23.00K |
Qube research | 34.09K | - | 34.09K | $21.21K |
Sold Out
Holder | Change |
---|---|
Ifp advisors | -1.00 |
Sterling capital management | -26.00 |
Nisa investment advisors | -196.00 |
Amalgamated bank | -880.00 |
Ameritas investment partners | -2.49K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 56 | -13.85% | 5,105,357 | -20.53% | 13 | 4.31% | 27 | -18.18% | 16 | 33.33% |
Mar 31, 2025 | 64 | 4.92% | 6,419,503 | 19.66% | 17 | 6.83% | 32 | 6.67% | 12 | 20.00% |
Dec 31, 2024 | 62 | 5.08% | 5,939,365 | 8.81% | 17 | 6.68% | 31 | -11.43% | 10 | 66.67% |
Sep 30, 2024 | 59 | 15.69% | 5,458,643 | 21.42% | 16 | 8.63% | 35 | -23.91% | 6 | 50.00% |
Jun 30, 2024 | 51 | 200.00% | 4,495,556 | 835.74% | 13 | 637.29% | 46 | 170.59% | 4 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 27, 2025 | Khoja Hamid | Chief Scientific Officer | Buy | $16.80K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 1 | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
FBLG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools